These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9683053)

  • 1. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
    Strauer BE; Schwartzkopff B
    Am J Hypertens; 1998 Jul; 11(7):879-81. PubMed ID: 9683053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The heart in hypertension].
    Hennersdorf MG; Strauer BE
    Internist (Berl); 2007 Mar; 48(3):236-45. PubMed ID: 17260148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
    De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
    Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.
    Schwartzkopff B; Brehm M; Mundhenke M; Strauer BE
    Hypertension; 2000 Aug; 36(2):220-5. PubMed ID: 10948081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.
    Motz W; Vogt M; Scheler S; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():100-6. PubMed ID: 1396852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
    Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
    Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
    Fogari R; Mugellini A; Destro M; Corradi L; Lazzari P; Zoppi A; Preti P; Derosa G
    Diabet Med; 2012 Jan; 29(1):24-31. PubMed ID: 21781149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of isradipine on the development of left ventricular hypertrophy in mild hypertension.
    Mehlsen J; Gleerup G; Haedersdal C; Winther K
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):95S-97S. PubMed ID: 8466741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 Jan; 3(1):8-15. PubMed ID: 2137344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients.
    Manolis AJ; Kolovou G; Handanis S; Athanasopoulos G; Antonopoulos S; Cokkinos DV
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):86S-88S. PubMed ID: 8466737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.